Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective observational study of sitagliptin in Japanese patients with type 2 diabetes (SCRUM)
jRCT1090220044Completed
- Sponsor
- Nagoya Medical Association
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Nagoya Medical Association. Primary endpoint: Change in HbA1c from baseline at 3 months. Started Aug 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1090220044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220044.